Shorts
0:39
PIM Inhibitor Shows Promise in High-Risk Myelofibrosis
7 months ago
by
Firas El Chaer, MD
0:24
More Than a Marker: Behind the Aggressive Nature of CD25+ Leukemias
7 months ago
by
Markus Müschen, MD, PhD
0:32
What’s Needed to Bring Clinical Trials to the Patient
7 months ago
by
Jason Hammonds
1:19
Can GLP-1 Agonists Help Treat Rare Cancers?
7 months ago
by
Erica Pimenta, MD, PhD
0:38
Initial Assessments in Metastatic RCC
7 months ago
by
David Braun, MD, PhD
0:35
The Future of Oncology Innovation is Moving to the Community
7 months ago
by
Jason Hammonds
0:36
Medicaid Expansion Saves Lives in Breast Cancer
7 months ago
by
Oluwasegun Akinyemi, MD, PhD
1:06
Understanding Co-Mutations and Real-Time ctDNA Monitoring in Lung Cancer
7 months ago
by
Estelamari Rodriguez, MD, MPH
0:32
Developing Novel Alpha-Emitting Agents in Prostate Cancer
7 months ago
by
Fred Saad, MD, FRCS
0:33
The Silent Crisis: Why Oncologists are Burning Out
7 months ago
by
Pallav K. Mehta, MD(+1 more)
0:38
The Future of Hybrid Healthcare
7 months ago
by
Pallav K. Mehta, MD(+1 more)
0:31
The Most 'Ripe' Areas for AI in Healthcare Right Now
7 months ago
by
Pallav K. Mehta, MD(+1 more)
0:33
The Challenge Isn't the Medicine—It's the Operations
7 months ago
by
Jason Hammonds
0:33
Predicting the Future: AI in the Medical Clinic
7 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:29
How AI Could Have Saved More Lives 10 Years Ago
7 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:44
How AI is Revolutionizing Precision Oncology
8 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:38
Why Macrophages are the Future of Cancer Therapy
8 months ago
by
Paolo Strati, MD
0:58
Findings From LITESPARK-011 Poised for Treatment Shift in RCC
8 months ago
by
Rahul A. Parikh, MD
0:44
Molecular Profiling and Neoadjuvant Care in Gyn Cancers
8 months ago
by
Erin Crane, MD, MPH
0:43
How Academic and Community Centers Can Better Collaborate on CAR T
8 months ago
by
Marc S. Hoffmann, MD
0:44
Breakthrough in Bladder Cancer: The KEYNOTE-B15 Clinical Trial
8 months ago
by
Rahul A. Parikh, MD
0:40
Closing the Access Gap: The Vital Role of the "Enthusiastic Recommendation"
8 months ago
by
Marc S. Hoffmann, MD
0:50
The Hidden Bias in Medical AI Algorithms
8 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:43
From Charting to Caring: How Technology and Delegation Save Clinician Time
8 months ago
by
Erin Crane, MD, MPH
0:32
The Search for a Functional Cure: Treating IGHV-Mutated CLL
8 months ago
by
Marc S. Hoffmann, MD
0:37
DNA Damage and Repair: Understanding pMMR and HRD in Gyn Cancers
8 months ago
by
Erin Crane, MD, MPH
0:36
Continuous vs Time-Limited: Navigating the Major Shift in CLL Care
8 months ago
by
Marc S. Hoffmann, MD
0:48
Beyond Standard Care: Navigating p53 Aberrant and 17p Deleted CLL
8 months ago
by
Marc S. Hoffmann, MD
0:33
How to Potentially Prevent 44% of Cancer Cases
8 months ago
by
Rebecca Siegel, MPH
0:52
Is Stage IV Lung Cancer Incurable? A New Breakthrough Says Otherwise
8 months ago
by
Saiesh Reddy Voppuru, MD
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Breakthrough Status to Multi-Cancer Early Detection Blood Test
2
FDA Clears Phase 2 Trial of B7-H3 CAR T MT027 for Brain Metastases
3
As New TGCT Therapies Advance, Route, Duration, and Coverage Shape CSF1R Inhibitor Choice
4
Alpha-Emitting RYZ101 Meets Phase 3 PFS End Point in Advanced GEP-NETs
5